Zobrazeno 1 - 10
of 26
pro vyhledávání: '"drug therapy [Dementia]"'
Publikováno v:
Journal of Alzheimer's disease 93(4), 1329-1339 (2023). doi:10.3233/JAD-221153
Background: Antibiotics for systemic use may increase the risk of neurodegeneration, yet antibiotic therapy may be able to halt or mitigate an episode of neurodegenerative decline. Objective: To investigate the association of sporadic use of antibiot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69a091e88f5919b1f9d8135d2cfee1b0
https://pub.dzne.de/record/258784
https://pub.dzne.de/record/258784
Publikováno v:
Journal of Alzheimer's disease 90(4), 1725-1737 (2022). doi:10.3233/JAD-220578
Background: The multimodal CORDIAL treatment concept for mild dementia, combining cognitive rehabilitation, cognitive behavioral and humanistic psychology interventions, has proven its feasibility and demonstrated a reduction of depressive symptoms i
Autor:
Moritz Platen, Steffen Flessa, Anika Rädke, Diana Wucherer, Jochen René Thyrian, Annelie Scharf, Wiebke Mohr, Franka Mühlichen, Wolfgang Hoffmann, Bernhard Michalowsky
Publikováno v:
Clinical drug investigation 42(5), 427-437 (2022). doi:10.1007/s40261-022-01151-9
BackgroundLow-value medications (Lvm) provide little or no benefit to patients, may be harmful, and waste healthcare resources and costs. Although evidence from the literature indicates that Lvm is highly prevalent in dementia, evidence about the fin
Publikováno v:
Journal of Alzheimer's disease 86(2), 703-709 (2022). doi:10.3233/JAD-215348
Background: Clinical trials have demonstrated a significant effectiveness of Ginkgo biloba therapy versus placebo in patients with dementia. Objective: The present study aims to analyze the impact of Ginkgo biloba drug prescriptions on dementia incid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99f781472f272950cca11b7ffca8a23d
Autor:
Damiana Scuteri, Shinobu Sakurada, Tsukasa Sakurada, Paolo Tonin, Giacinto Bagetta, Pierluigi Nicotera, Maria Tiziana Corasaniti
Publikováno v:
Current pharmaceutical design 28(20), 1607-1610 (2022). doi:10.2174/1381612828666220509152029
Abstract: Due to the tight link between undertreated pain and agitation in dementia patients, aromatherapy can be a useful approach if an essential oil (EO) with powerful analgesic activity is used. The methodological difficulties of most aromatherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd6c63a81d318d33d1b8edab90c3ac02
Publikováno v:
Journal of Alzheimer's disease 73(1), 175-183 (2020). doi:10.3233/JAD-190444
Background Recent evidence indicates an important role for neuroinflammation in the pathological cascade of Alzheimer's disease (AD), and neuroinflammation is increasingly being recognized as a potential therapeutic target. Objective To assess the im
Autor:
D, Scuteri, F, Guida, S, Boccella, L, Luongo, S, Maione, P, Tonin, P, Nicotera, G, Bagetta, M T, Corasaniti
Publikováno v:
Biomedicine & pharmacotherapy 153, 113488 (2022). doi:10.1016/j.biopha.2022.113488
Up to 80 % nursing home residents with dementia experiences chronic pain. Contextually, 97 % presents fluctuant neuropsychiatric symptoms (NPS). Among the most challenging is agitation, connected with undertreated pain and managed through neuroleptic
Publikováno v:
Current opinion in pharmacology 65, 102237 (2022). doi:10.1016/j.coph.2022.102237
Autor:
Guido Bigliardi, Fabrizio Piazza, Paolo Frigio Nichelli, Loris Poli, Roberto Gasparotti, Alessandro Pezzini, V. De Giuli, Alessandro Padovani, Andrea Zini, Irene Volonghi, Stefano Vallone
Publikováno v:
Journal of neuroimmunology. 338
Cerebral amyloid angiopathy-related inflammation (CAA-ri) is a rare and treatable variant of CAA likely due to an autoimmune response directed toward beta-amyloid deposits. Cognitive and behavioral manifestations are the most common symptoms, followe
Autor:
Ralph Möhler, Hendrika J Luijendijk, Sascha Köpke, Sytse U Zuidema, Martin N. Dichter, Viktoria Mühlbauer
Publikováno v:
Cochrane library 12, CD013304 (2021). doi:10.1002/14651858.CD013304.pub2
Cochrane library 4, CD013304 (2019). doi:10.1002/14651858.CD013304
Cochrane Database Syst Rev
Cochrane library 4, CD013304 (2019). doi:10.1002/14651858.CD013304
Cochrane Database Syst Rev
BACKGROUND: Typical and atypical antipsychotics are widely used to treat agitation and psychosis in dementia. However, whether or not they are beneficial is uncertain. Some trials have yielded negative results and effectiveness may be outweighed by h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4021c51c79030fcbaaae358b10691465